MedPath

GIANVI

Gianvi™(drospirenone and ethinyl estradiol tablets)Rev. D 6/201011001685

Approved
Approval ID

78f2664f-3de8-4e58-a860-1b5abd6eb7d7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 11, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

drospirenone and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6162
Application NumberANDA078515
Product Classification
M
Marketing Category
C73584
G
Generic Name
drospirenone and ethinyl estradiol
Product Specifications
Effective DateOctober 22, 2010
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GIANVI - FDA Drug Approval Details